Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

From Practice-Changing Data to Future Innovation, Patient Outcomes to Doctors’ Wellbeing,...

Ogkologos - 13 Σεπτεμβρίου, 2024

ESMO 2024 Press Conference

Ogkologos - 13 Σεπτεμβρίου, 2024

Doxorubicin and Trabectedin Combination Improves Survival Among Patients with Metastatic or...

Ogkologos - 13 Σεπτεμβρίου, 2024

FDA Approves Daratumumab and Hyaluronidase-fihj with Bortezomib, Lenalidomide, and Dexamethasone for...

Ogkologos - 12 Σεπτεμβρίου, 2024

Study Identifies Hundreds of Potential Targets for Cancer Drugs

Ogkologos - 11 Σεπτεμβρίου, 2024

Six Years of Adjuvant Imatinib Improves DFS Over Three Years Treatment...

Ogkologos - 11 Σεπτεμβρίου, 2024

ESMO Calls for Concerted Action to Prevent Burnout and Foster Well-Being...

Ogkologos - 10 Σεπτεμβρίου, 2024

Tarlatamab Demonstrates Sustained Clinical Benefit and Potential Findings of Intracranial Activity...

Ogkologos - 10 Σεπτεμβρίου, 2024

FDA Approves Lazertinib with Amivantamab-vmjw for Locally Advanced or Metastatic NSCLC...

Ogkologos - 9 Σεπτεμβρίου, 2024

Studies Provide First Evidence That Breastfeeding after Breast Cancer Is Safe

Ogkologos - 8 Σεπτεμβρίου, 2024

1...707172...440 Σελίδα 71 από 440

MOST POPULAR

FDA Approvals Expand Initial Treatment Options for Multiple Myeloma

7 Ιανουαρίου, 2025

Intratumoural Administration of the Oncolytic Herpes Virus Shows Survival Benefit and...

18 Αυγούστου, 2022

FDA Proposes Rule Prohibiting Menthol Cigarettes

27 Ιουνίου, 2022

Clinical Trials in Genitourinary Cancers: TALAPRO-2, KEYNOTE-905, and COSMIC-313

9 Ιουλίου, 2020

Φόρτωση περισσοτέρων

From Practice-Changing Data to Future Innovation, Patient Outcomes to Doctors’ Wellbeing,...

ESMO 2024 Press Conference

Doxorubicin and Trabectedin Combination Improves Survival Among Patients with Metastatic or...

FDA Approves Daratumumab and Hyaluronidase-fihj with Bortezomib, Lenalidomide, and Dexamethasone for...

Study Identifies Hundreds of Potential Targets for Cancer Drugs

Six Years of Adjuvant Imatinib Improves DFS Over Three Years Treatment...

ESMO Calls for Concerted Action to Prevent Burnout and Foster Well-Being...

Tarlatamab Demonstrates Sustained Clinical Benefit and Potential Findings of Intracranial Activity...

FDA Approves Lazertinib with Amivantamab-vmjw for Locally Advanced or Metastatic NSCLC...

Studies Provide First Evidence That Breastfeeding after Breast Cancer Is Safe

MOST POPULAR

FDA Approvals Expand Initial Treatment Options for Multiple Myeloma

Intratumoural Administration of the Oncolytic Herpes Virus Shows Survival Benefit and...

FDA Proposes Rule Prohibiting Menthol Cigarettes

Clinical Trials in Genitourinary Cancers: TALAPRO-2, KEYNOTE-905, and COSMIC-313

HOT NEWS

Spending Review 2021: Promising commitments, but a lot of unanswered questions

What Do You Put In Your Pocket?

ESMO Breast Cancer Congress 2023

EMA Recommends Extending Indications for Pembrolizumab and Adopted a New Pharmaceutical...

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ